
Long-acting cabotegravir and lenacapavir both deliver near-complete protection. The faculty compare dosing schedules, drug interactions, and injection site reactions, and share techniques that make injections easier to tolerate.

Long-acting cabotegravir and lenacapavir both deliver near-complete protection. The faculty compare dosing schedules, drug interactions, and injection site reactions, and share techniques that make injections easier to tolerate.

Four approved PrEP options now span daily pills and long-acting injections. The faculty review how each agent works and where daily oral PrEP succeeds or falls short in practice.

Every clinician can prescribe or refer for PrEP. The faculty outline the education, team structures, and community outreach that build prescriber confidence, and explain why HIV prevention still matters in the treatment era.

A gap between perceived and actual risk, messaging that has not reached women, and long drive times to a prescriber all limit PrEP uptake. The faculty examine what sustains PrEP deserts and how to bridge them.

Confirming HIV-negative status before starting PrEP, and at every follow-up, protects against partial treatment and drug resistance. The faculty compare testing strategies across clinical and pharmacy settings.

Patients rarely ask about PrEP unless someone asks first. The faculty describe how primary care clinicians and community pharmacists can open the conversation with confidence and without judgment.

See how PrEP blocks HIV, who benefits most, and why access gaps hit women, youth, and the South—plus ways to close them.

Endocrinology experts discuss the clinical implications of off-target TSH levels and stress the importance of stabilizing these levels for hypothyroidism management.

Endocrinology experts share their practical approaches for monitoring TSH levels and providing follow-up to hypothyroidism treatment.

Experts in endocrinology share their insights into the clinical practicalities of the different types and formulations of levothyroxine treatment in patients with hypothyroidism.

Drs James Hennessey and Antonio Bianco share their insights into the role that diet and calorie restriction can have on thyroid-stimulating hormone[TSH] levels for patients with hypothyroidism.

Antonio Bianco, MD, PhD, shares considerations for using consistent LT4 formulation and highlights the role of pharmacists in maintaining consistent LT4 prescriptions for patients with hypothyroidism.

Drs James Hennessey and Antonio Bianco talk about the optimization of levothyroxine in elderly patients with hypothyroidism.

James Hennessey, MD, FACP, and Antonio Bianco, MD, PhD, discuss the role of age and concomitant drug interactions in maintaining optimal TSH levels for hypothyroidism management.

Experts in endocrinology review the impact of proper and consistent treatment adherence to maintain TSH levels and the role diet and dosing timing plays in managing hypothyroidism.

James Hennessey, MD, FACP, provides an overview of clinical trial data for patients with hypothyroidism, highlighting the negative effect and poor health-related consequences of off target TSH levels.

Experts in endocrinology comment on the importance of maintaining TSH levels in normal target ranges and highlight the prevalence of patients with hypothyroidism not maintaining these targets.

Drs James Hennessey and Antonio Bianco examine the differences in prevalence between overt and subclinical hypothyroidism.

James Hennessey, MD, FACP, and Antonio Bianco, MD, PhD, discuss the prevalence of hypothyroidism and the role of thyroid hormone replacement therapy in managing the condition.